Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation
Nami Nakagomi(Hyogo Medical University), Seiichi Hirota(Hyogo Medical University)
Cited by 65
Related Papers
Secondary mutations in the kinase domain of the <i> KIT</i> gene are predominant in imatinib‐resistant gastrointestinal stromal tumor
|Cancer Science|2008|111
Different inhibitory effect of imatinib on phosphorylation of mitogen‐activated protein kinase and Akt and on proliferation in cells expressing different types of mutant platelet‐derived growth factor receptor‐α
|International Journal of Cancer|2004|17
Epithelioid glioblastoma with microglia features: potential for novel therapy
|Brain Pathology|2020|13
In vivo effect of imatinib on progression of cecal GIST-like tumors in exon 17-type c-kit knock-in mice
|Laboratory Investigation|2009|9